Long-term outcomes after stenting of bifurcation lesions with the "crush" technique - Predictors of an adverse outcome

被引:198
作者
Hoye, Angela
Iakovou, Ioannis
Ge, Lei
van Mieghem, Carlos A. G.
Ong, Andrew T. L.
Cosgrave, John
Sanglorgi, Giuseppe M.
Airoldi, Flavio
Montorfano, Matteo
Michev, Iassen
Chieffo, Alaide
Carlino, Mauro
Corvaja, Nicola
Aoki, Jiro
Granillo, Gaston A. Rodriguez
Valgimigli, Marco
Sianos, Georgios
van der Giessen, Willem J.
de Feyter, Pim J.
van Domburg, Ron T.
Serruys, Patrick W.
Colombo, Antonio
机构
[1] Erasmus Med Ctr, Thoraxctr, NL-3015 GD Rotterdam, Netherlands
[2] EMO, Ctr Cuore Columbus, Milan, Italy
[3] Hosp San Raffaele, I-20132 Milan, Italy
关键词
D O I
10.1016/j.jacc.2005.11.083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this study was to evaluate predictors of an adverse outcome after "crush" bifurcation stenting. BACKGROUND The "crush" technique is a recently introduced strategy with limited data regarding long-term outcomes. METHODS We identified 231 consecutive patients treated with drug-eluting stent implantation with the "crush" technique for 241 de novo bifurcation lesions. Clinical follow-up was obtained in 99.6%. RESULTS The in-hospital major adverse cardiac event (MACE) rate was 5.2%. At 9 months, 10 (4.3%) patients had an event consistent with possible post-procedural stent thrombosis. Survival free of target lesion revascularization (TLR) was 90.3%; the only independent predictor of TLR was left main stem (LMS) therapy (odds ratio [OR] 4.97; 95% confidence interval [Cl] 2.00 to 12.37, p = 0.001). Survival free of MACE was 83.5% and independent predictors of MACE were LMS therapy (OR 3.79; 95% CI 1.76 to 8.14, p = 0.001) and treatment of patients with multivessel disease (OR 4.21; 95% CI 0.95 to 18.56, p = 0.058). Angiographic follow-up was obtained in 77% of lesions at 8.3 +/- 3.7months. The mean late loss of the main vessel and side branch were 0.30 +/- 0.64 mm and 0.41 +/- 0.67 mm, respectively, with binary restenosis rates of 9.1% and 25.3%. Kissing balloon post-dilation significantly reduced the side branch late lumen loss (0.24 +/- 0.50 mm vs. 0.58 +/- 0.77 mm, p < 0.001). CONCLUSIONS The crush technique of bifurcation stenting with drug-eluting stents is associated with favorable outcomes for most lesions; however, efficacy appears significantly reduced in LMS bifurcations, and further research is needed before the technique can be routinely recommended in this group. Furthermore, the incidence of possible stent thrombosis is of concern and requires further investigation. Kissing balloon post-dilatation is mandatory to reduce side branch restenosis. (J Am Coll Cardiol 2006;47:1949-58) (c) 2006 by the American College of Cardiology Foundation.
引用
收藏
页码:1949 / 1958
页数:10
相关论文
共 31 条
[1]   Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions [J].
Al Suwaidi, J ;
Berger, PB ;
Rihal, CS ;
Garratt, KN ;
Bell, MR ;
Ting, HH ;
Bresnahan, JF ;
Grill, DE ;
Holmes, DR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (04) :929-936
[2]   Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI Dynamic Registry) [J].
Al Suwaidi, J ;
Yeh, WL ;
Cohen, HA ;
Detre, KM ;
Williams, DO ;
Holmes, DR .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (10) :1139-1144
[3]   Immediate and long-term clinical and angiographic results from Wiktor stent treatment for true bifurcation narrowings [J].
Anzuini, A ;
Briguori, C ;
Rosanio, S ;
Tocchi, M ;
Pagnotta, P ;
Bonnier, H ;
Gimelli, G ;
Airoldi, F ;
Margonato, A ;
Legrand, V ;
Colombo, A .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (11) :1246-1250
[4]   Elective sirolimus-eluting stent implantation for left main coronary artery disease: Six-month angiographic follow-up and 1-year clinical outcome [J].
Arampatzis, CA ;
Lemos, PA ;
Hoye, A ;
Saia, F ;
Tanabe, K ;
van der Giessen, WJ ;
Smits, PC ;
McFadden, E ;
de Feyter, P ;
Serruys, PW .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 62 (03) :292-296
[5]   The contribution of "mechanical" problems to in-stent restenosis: An intravascular ultrasonographic analysis of 1090 consecutive in-stent restenosis lesions [J].
Castagna, MT ;
Mintz, GS ;
Leiboff, BO ;
Ahmed, JM ;
Mehran, R ;
Satler, LF ;
Kent, KM ;
Pichard, AD ;
Weissman, NJ .
AMERICAN HEART JOURNAL, 2001, 142 (06) :970-974
[6]   Early and mid-term results of drug-eluting dtent implantation in unprotected left main [J].
Chieffo, A ;
Stankovic, G ;
Bonizzoni, E ;
Tsagalou, E ;
Iakovou, I ;
Montorfano, M ;
Airoldi, F ;
Michev, I ;
Sangiorgi, MG ;
Carlino, M ;
Vitrella, G ;
Colombo, A .
CIRCULATION, 2005, 111 (06) :791-795
[7]   Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents [J].
Chieffo, A ;
Bonizzoni, E ;
Orlic, D ;
Stankovic, G ;
Rogacka, R ;
Airoldi, F ;
Mikhail, GW ;
Montorfano, M ;
Michev, I ;
Carlino, M ;
Colombo, A .
CIRCULATION, 2004, 109 (22) :2732-2736
[8]   Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions [J].
Colombo, A ;
Moses, JW ;
Morice, MC ;
Ludwig, J ;
Holmes, DR ;
Spanos, V ;
Louvard, Y ;
Desmedt, B ;
Di Mario, C ;
Leon, MB .
CIRCULATION, 2004, 109 (10) :1244-1249
[9]   Bifurcational lesions and the "Crush" technique: Understanding why it works and why it doesn't - A kiss is not just a kiss [J].
Colombo, A .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 63 (03) :337-338
[10]   Modified T-stenting technique with crushing for bifurcation lesions: Immediate results and 30-day outcome [J].
Colombo, A ;
Stankovic, G ;
Orlic, D ;
Corvaja, N ;
Liistro, F ;
Airoldi, F ;
Chieffo, A ;
Spanos, V ;
Montorfano, M ;
Di Mario, C .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 60 (02) :145-151